Literature DB >> 28758322

Smallest detectable change and test-retest reliability of a self-reported outcome measure: Results of the Center for Epidemiologic Studies Depression Scale, General Self-Efficacy Scale, and 12-item General Health Questionnaire.

Shotaro Ohno1, Kana Takahashi1, Aimi Inoue1, Koki Takada1, Yoshiaki Ishihara1, Masaru Tanigawa1, Kazuki Hirao1.   

Abstract

RATIONALE, AIMS, AND
OBJECTIVES: This study aims to examine the smallest detectable change (SDC) and test-retest reliability of the Center for Epidemiologic Studies Depression Scale (CES-D), General Self-Efficacy Scale (GSES), and 12-item General Health Questionnaire (GHQ-12).
METHOD: We tested 154 young adults at baseline and 2 weeks later. We calculated the intra-class correlation coefficients (ICCs) for test-retest reliability with a two-way random effects model for agreement. We then calculated the standard error of measurement (SEM) for agreement using the ICC formula. The SEM for agreement was used to calculate SDC values at the individual level (SDCind ) and group level (SDCgroup ).
RESULTS: The study participants included 137 young adults. The ICCs for all self-reported outcome measurement scales exceeded 0.70. The SEM of CES-D was 3.64, leading to an SDCind of 10.10 points and SDCgroup of 0.86 points. The SEM of GSES was 1.56, leading to an SDCind of 4.33 points and SDCgroup of 0.37 points. The SEM of GHQ-12 with bimodal scoring was 1.47, leading to an SDCind of 4.06 points and SDCgroup of 0.35 points. The SEM of GHQ-12 with Likert scoring was 2.44, leading to an SDCind of 6.76 points and SDCgroup of 0.58 points.
CONCLUSION: To confirm that the change was not a result of measurement error, a score of self-reported outcome measurement scales would need to change by an amount greater than these SDC values. This has important implications for clinicians and epidemiologists when assessing outcomes.
© 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  depression; measurement error; mental health; minimal detectable change; smallest detectable change; standard error of measurement

Mesh:

Year:  2017        PMID: 28758322     DOI: 10.1111/jep.12795

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  5 in total

1.  An iPad application-based intervention for improving post-stroke depression symptoms in a convalescent rehabilitation ward: A pilot randomized controlled clinical trial protocol.

Authors:  Hiroyuki Uchida; Yoshiya Hiragaki; Yuta Nishi; Shiori Nakahara; Junki Koumoto; Yusuke Onmyoji; Norimasa Fujimoto; Kazuho Kawakami; Masato Ishii; Kazuki Hirao
Journal:  Internet Interv       Date:  2020-08-27

2.  Objective Job Demands of Oneself and One's Partner, and Depressive Symptoms. Evidence from a Nationally Representative Longitudinal Study.

Authors:  Benedikt Kretzler; Hans-Helmut König; André Hajek
Journal:  Int J Environ Res Public Health       Date:  2021-12-01       Impact factor: 3.390

3.  Delivering Personalized Recommendations to Support Caregivers of People Living With Dementia: Mixed Methods Study.

Authors:  Jinhee Cha; Colleen M Peterson; Ashley N Millenbah; Katie Louwagie; Zachary G Baker; Ayush Shah; Christine J Jensen; Joseph E Gaugler
Journal:  JMIR Aging       Date:  2022-05-03

4.  Study protocol for a pilot randomized controlled trial on a smartphone application-based intervention for subthreshold depression: Study protocol clinical trial (SPIRIT Compliant).

Authors:  Yudai Kato; Kaito Kageyama; Takanori Mesaki; Hiroyuki Uchida; Yoshiyuki Sejima; Risako Marume; Kana Takahashi; Kazuki Hirao
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

5.  Measuring health-related quality of life in chronic headache: A comparative evaluation of the Chronic Headache Quality of Life Questionnaire and Headache Impact Test (HIT-6).

Authors:  Kirstie L Haywood; Felix Achana; Vivien Nichols; Gemma Pearce; Barbara Box; Lynne Muldoon; Shilpa Patel; Frances Griffiths; Kimberly Stewart; Martin Underwood; Manjit M Matharu
Journal:  Cephalalgia       Date:  2021-05-04       Impact factor: 6.292

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.